日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Hydrogel-mediated tri-modal nanoplatform for localized colorectal cancer therapy via smart chemo-photothermal-radiotherapy

基于水凝胶的三模式纳米平台，通过智能化疗-光热-放疗实现局部结直肠癌治疗

期刊:Journal of Biological Engineering
影响因子:6.5
doi:10.1186/s13036-026-00633-0
Shi, Yanlong; Ding, Sentai; Wang, Zexin; Li, Leping; Wang, Jinshen; Mehdizadeh, Sepehr; Pilehvar, Younes
肿瘤
肠癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Comparative study of intelligent sensory technologies combined multiple metabolomics in evaluating sensory attributes and health profiles across different grades and varieties of green tea-processed mulberry leaf tea

本研究采用多种代谢组学方法，对不同等级和品种的桑叶绿茶进行感官特性和健康指标的评价，并比较了智能感官技术的应用。

期刊:Food Chemistry-X
影响因子:8.2
doi:10.1016/j.fochx.2025.102518
Lin, Junhui; Yang, Zhangchang; Li, Qian; Wang, Weifei; Liao, Sentai; Xing, Dongxu; Chen, Ruohong; Pang, Daorui; Zou, Yuxiao
代谢
发表日期：2025
文献求助 收藏

Dietary supplementation of mulberry leaf oligosaccharides improves the growth, glucose and lipid metabolism, immunity, and virus resistance in largemouth bass (Micropterus salmoides)

膳食补充桑叶寡糖可改善大口黑鲈（Micropterus salmoides）的生长、葡萄糖和脂质代谢、免疫力和抗病毒能力。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1525992
Zhou, Donglai; Zhong, Wenhao; Fu, Bing; Li, Erna; Hao, Le; Li, Qingrong; Yang, Qiong; Zou, Yuxiao; Liu, Zhenxing; Wang, Fubao; Liao, Sentai; Xing, Dongxu
微生物学
代谢
免疫/内分泌
发表日期：2025
文献求助 收藏

Efficacy and safety of Tislelizumab combined with Axitinib as first-line treatment for intermediate- and high-risk metastatic clear-cell renal cell carcinoma

替利珠单抗联合阿昔替尼一线治疗中高危转移性透明细胞肾细胞癌的疗效和安全性

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1618898
Cui, Jie; Xu, Pengyong; Guo, Changying; Guan, Yong; Zhu, Kejia; Ding, Sentai
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Safety assessment of ripretinib: a real-world adverse event analysis from the food and drug administration adverse event reporting system

瑞普替尼安全性评估：来自美国食品药品监督管理局不良事件报告系统的真实世界不良事件分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1542315
Wang, Sentai; Chen, Hewen; Zhou, Yuying; Chen, Jianfeng; Cao, Jiwei
发表日期：2025
文献求助 收藏

JMJD8 overexpression in breast cancer: implications for diagnosis, prognosis, and immune microenvironment interactions.

JMJD8 在乳腺癌中的过度表达：对诊断、预后和免疫微环境相互作用的影响

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1536278
Zhu Chenlei, Xi Tianyi, Yang Guorong, Lu Wen, Wang Sentai, Cao Jiwei
肿瘤
乳腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma: A narrative review

免疫检查点抑制剂疗法作为肌层浸润性膀胱癌的新辅助治疗：一篇叙述性综述

期刊:Current Urology
影响因子:1.3
doi:10.1097/CU9.0000000000000263
Ding, Sentai; Wu, Chenrui; Cao, Jishuang; Lyu, Jiaju
肿瘤
肿瘤免疫
膀胱癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Expression of HER2 in urothelial carcinoma and its significance

HER2在尿路上皮癌中的表达及其意义

期刊:Current Urology
影响因子:1.3
doi:10.1097/CU9.0000000000000249
Chang, Yao; Zhao, Delong; Wang, Zicheng; Zhu, Kejia; Guo, Andong; Cao, Jishuang; Wu, Chenrui; Ding, Sentai
肿瘤
肿瘤免疫
HER2
发表日期：2025
文献求助 收藏

Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients

基于中国专家共识的高级别尿路上皮癌中HER2的表达及disitamab vedotin-tislelizumab联合疗法治疗晚期患者的临床疗效

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1355081
Zhu, Kejia; Chang, Yao; Zhao, Delong; Guo, Andong; Cao, Jishuang; Wu, Chenrui; Guan, Yong; Ding, Sentai
肿瘤
肿瘤免疫
HER2
发表日期：2024
文献求助 收藏

Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics

HER2在尿路上皮癌中的临床意义及其与糖酵解代谢特征的相关性分析

期刊:Frontiers in Molecular Biosciences
影响因子:4
doi:10.3389/fmolb.2024.1521889
Guo, Andong; Wu, Chenrui; Cao, Jishuang; Zhu, Kejia; Ding, Sentai
肿瘤
肿瘤免疫
HER2
代谢
发表日期：2024
文献求助 收藏